{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:48:17Z","timestamp":1794466097165,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["OPP1173131"],"award-info":[{"award-number":["OPP1173131"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["K43TW011006"],"award-info":[{"award-number":["K43TW011006"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"name":"South African National Research Foundation"},{"name":"South African National Research Foundation"},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["MR\/R007942\/1"],"award-info":[{"award-number":["MR\/R007942\/1"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["TMA2019SFP-2836 TB lung-FACT2"],"award-info":[{"award-number":["TMA2019SFP-2836 TB lung-FACT2"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010147","name":"Asociaci\u00f3n Espa\u00f1ola de Pediatr\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010147","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008054","name":"Fundaci\u00f3n Ram\u00f3n Areces","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"UK Medical Research Council and UK Foreign, Commonwealth and Development Office"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Tuberculosis (TB)-associated mortality in South Africa remains high. This review aimed to systematically assess risk factors associated with death during TB treatment in South African patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We conducted a systematic review of TB research articles published between 2010 and 2018. We searched BioMed Central (BMC), PubMed\u00ae, EBSCOhost, Cochrane, and SCOPUS for publications between January 2010 and December 2018. Searches were conducted between August 2019 and October 2019. We included randomised control trials (RCTs), case control, cross sectional, retrospective, and prospective cohort studies where TB mortality was a primary endpoint and effect measure estimates were provided for risk factors for TB mortality during TB treatment. Due to heterogeneity in effect measures and risk factors evaluated, a formal meta-analysis of risk factors for TB mortality was not appropriate. A random effects meta-analysis was used to estimate case fatality ratios (CFRs) for all studies and for specific subgroups so that these could be compared. Quality assessments were performed using the Newcastle-Ottawa scale or the Cochrane Risk of Bias Tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 1995 titles for screening, 24 publications met our inclusion criteria (one cross-sectional study, 2 RCTs, and 21 cohort studies). Twenty-two studies reported on adults (<jats:italic>n<\/jats:italic>\u00a0=\u00a012561) and two were restricted to children &lt;\u00a015\u00a0years of age (<jats:italic>n<\/jats:italic>\u00a0=\u00a0696). The CFR estimated for all studies was 26.4% (CI 18.1\u201334.7, <jats:italic>n<\/jats:italic>\u00a0=\u00a013257 ); 37.5% (CI 24.8-50.3, <jats:italic>n<\/jats:italic>\u00a0=\u00a05149) for drug-resistant (DR) TB; 12.5% (CI 1.1\u201323.9, <jats:italic>n<\/jats:italic>\u00a0=\u00a01935) for drug-susceptible (DS) TB; 15.6% (CI 8.1\u201323.2, <jats:italic>n<\/jats:italic>\u00a0=\u00a06173) for studies in which drug susceptibility was mixed or not specified; 21.3% (CI 15.3-27.3, <jats:italic>n<\/jats:italic>\u00a0=\u00a07375) for people living with HIV\/AIDS (PLHIV); 19.2% (CI 7.7\u201330.7, <jats:italic>n<\/jats:italic>\u00a0=\u00a01691) in HIV-negative TB patients; and 6.8% (CI 4.9\u20138.7, <jats:italic>n<\/jats:italic>\u00a0=\u00a0696) in paediatric studies. The main risk factors associated with TB mortality were HIV infection, prior TB treatment, DR-TB, and lower body weight at TB diagnosis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In South Africa, overall mortality during TB treatment remains high, people with DR-TB have an elevated risk of mortality during TB treatment and interventions to mitigate high mortality are needed. In addition, better prospective data on TB mortality are needed, especially amongst vulnerable sub-populations including young children, adolescents, pregnant women, and people with co-morbidities other than HIV. Limitations included a lack of prospective studies and RCTs and a high degree of heterogeneity in risk factors and comparator variables.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>The systematic review protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under the registration number CRD42018108622. This study was funded by the Bill and Melinda Gates Foundation (Investment ID OPP1173131) via the South African TB Think Tank.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13643-023-02175-8","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T06:27:37Z","timestamp":1677133657000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["A systematic review of risk factors for mortality among tuberculosis patients in South Africa"],"prefix":"10.1186","volume":"12","author":[{"given":"Tamaryn J","family":"Nicholson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Hoddinott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Seddon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mareli M","family":"Claassens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M","family":"van der Zalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawood","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celeste","family":"de Vaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Du Preez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke C","family":"Hesseling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebrahim","family":"Kriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Loveday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian M","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue-Ann","family":"Meehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Purchase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kogieleum","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenny","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadelah","family":"Solomon-Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sloot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3818-9729","authenticated-orcid":false,"given":"Muhammad","family":"Osman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"2175_CR1","unstructured":"World Health Organization. Definitions and reporting framework for tuberculosis \u2013 2013 revision (Updated December 2014 and January 2020). Geneva, Switzerland: WHO Press, 2020. Report No.: 978 92 4 150534 5."},{"key":"2175_CR2","volume-title":"Global Tuberculosis Report 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Global Tuberculosis Report 2022. Geneva: Switzerland; 2022."},{"key":"2175_CR3","volume-title":"The End TB Strategy","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. The End TB Strategy. Geneva: Switzerland; 2015."},{"key":"2175_CR4","volume-title":"Global Tuberculosis Report 2020","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Global Tuberculosis Report 2020. Geneva: Switzerland; 2020."},{"key":"2175_CR5","unstructured":"Statistics South Africa. Mortality and causes of death in South Africa: Findings from death notification, 2018. Pretoria, South Africa., 2021."},{"issue":"7","key":"2175_CR6","doi-asserted-by":"publisher","first-page":"871","DOI":"10.5588\/ijtld.10.0352","volume":"15","author":"CJ Waitt","year":"2011","unstructured":"Waitt CJ, Squire SB. A systematic review of risk factors for death in adults during and after tuberculosis treatment. Int J Tuberc Lung Dis. 2011;15(7):871\u201385.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2175_CR7","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1186\/s12889-015-1914-z","volume":"15","author":"M Osman","year":"2015","unstructured":"Osman M, Seddon JA, Dunbar R, Draper HR, Lombard C, Beyers N. The complex relationship between human immunodeficiency virus infection and death in adults being treated for tuberculosis in Cape Town. South Africa BMC Public Health. 2015;15:556.","journal-title":"South Africa. BMC Public Health"},{"issue":"1","key":"2175_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12889-016-3972-2","volume":"17","author":"JC Heunis","year":"2017","unstructured":"Heunis JC, Kigozi NG, Chikobvu P, Botha S, van Rensburg HD. Risk factors for mortality in TB patients: a 10-year electronic record review in a South African province. BMC Public Health. 2017;17(1):38.","journal-title":"BMC Public Health"},{"issue":"5","key":"2175_CR9","doi-asserted-by":"publisher","first-page":"362","DOI":"10.7196\/SAMJ.7655","volume":"104","author":"JV Ershova","year":"2014","unstructured":"Ershova JV, Podewils LJ, Bronner LE, Stockwell HG, Dlamini SS, Mametja LD. Evaluation of adherence to national treatment guidelines among tuberculosis patients in three provinces of South Africa. S Afr Med J. 2014;104(5):362\u20138.","journal-title":"S Afr Med J"},{"issue":"4","key":"2175_CR10","doi-asserted-by":"publisher","first-page":"849","DOI":"10.4314\/ahs.v14i4.12","volume":"14","author":"TE Mabunda","year":"2014","unstructured":"Mabunda TE, Ramalivhana NJ, Dambisya YM. Mortality associated with tuberculosis\/HIV co-infection among patients on TB treatment in the Limpopo province. South Africa Afr Health Sci. 2014;14(4):849\u201354.","journal-title":"South Africa. Afr Health Sci"},{"issue":"1","key":"2175_CR11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1164\/rccm.200907-0989OC","volume":"181","author":"NR Gandhi","year":"2010","unstructured":"Gandhi NR, Shah NS, Andrews JR, et al. HIV coinfection in multidrug- and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med. 2010;181(1):80\u20136.","journal-title":"Am J Respir Crit Care Med"},{"key":"2175_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ijid.2015.09.002","volume":"39","author":"K Schnippel","year":"2015","unstructured":"Schnippel K, Shearer K, Evans D, Berhanu R, Dlamini S, Ndjeka N. Predictors of mortality and treatment success during treatment for rifampicin-resistant tuberculosis within the South African National TB Programme, 2009 to 2011: a cohort analysis of the national case register. Int J Infect Dis. 2015;39:89\u201394.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2175_CR13","doi-asserted-by":"publisher","first-page":"126","DOI":"10.2471\/BLT.13.124800","volume":"92","author":"P MacPherson","year":"2014","unstructured":"MacPherson P, Houben RM, Glynn JR, Corbett EL, Kranzer K. Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis. Bull World Health Organ. 2014;92(2):126\u201338.","journal-title":"Bull World Health Organ"},{"issue":"11","key":"2175_CR14","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.5588\/ijtld.15.0222","volume":"19","author":"T Omar","year":"2015","unstructured":"Omar T, Variava E, Moroe E, et al. Undiagnosed TB in adults dying at home from natural causes in a high TB burden setting: a post-mortem study. Int J Tuberc Lung Dis. 2015;19(11):1320\u20135.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"2175_CR15","doi-asserted-by":"publisher","first-page":"90","DOI":"10.7196\/SAMJ.5363","volume":"102","author":"M Tiemensma","year":"2012","unstructured":"Tiemensma M, Burger EH. Sudden and unexpected deaths in an adult population, Cape Town, South Africa, 2001\u20132005. S Afr Med J. 2012;102(2):90\u20134.","journal-title":"S Afr Med J"},{"issue":"10","key":"2175_CR16","first-page":"1182","volume":"12","author":"KP Shean","year":"2008","unstructured":"Shean KP, Willcox PA, Siwendu SN, et al. Treatment outcome and follow-up of multidrug-resistant tuberculosis patients, West Coast\/Winelands, South Africa, 1992\u20132002. Int J Tuberc Lung Dis. 2008;12(10):1182\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"9924","key":"2175_CR17","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/S0140-6736(13)62675-6","volume":"383","author":"E Pietersen","year":"2014","unstructured":"Pietersen E, Ignatius E, Streicher EM, et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet. 2014;383(9924):1230\u20139.","journal-title":"Lancet"},{"issue":"1","key":"2175_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.5588\/ijtld.11.0153","volume":"16","author":"NR Gandhi","year":"2012","unstructured":"Gandhi NR, Andrews JR, Brust JC, et al. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting. Int J Tuberc Lung Dis. 2012;16(1):90\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"81","key":"2175_CR19","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1741-7015-9-81","volume":"9","author":"MA Baker","year":"2011","unstructured":"Baker MA, Harries AD, Jeon CY, et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011;9(81):81.","journal-title":"BMC Med"},{"key":"2175_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"2175_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339: b2700.","journal-title":"BMJ"},{"issue":"4","key":"2175_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.pedhc.2021.04.011","volume":"35","author":"MK Swartz","year":"2021","unstructured":"Swartz MK. PRISMA 2020: an update. Journal of Pediatric Health Care. 2021;35(4):351.","journal-title":"Journal of Pediatric Health Care"},{"issue":"4","key":"2175_CR23","doi-asserted-by":"publisher","first-page":"e2020032490","DOI":"10.1542\/peds.2020-032490","volume":"147","author":"M Osman","year":"2021","unstructured":"Osman M, du Preez K, Seddon JA, et al. Mortality in South African children and adolescents routinely treated for tuberculosis. Pediatrics. 2021;147(4):e2020032490.","journal-title":"Pediatrics"},{"issue":"1","key":"2175_CR24","doi-asserted-by":"publisher","first-page":"15894","DOI":"10.1038\/s41598-021-95331-w","volume":"11","author":"M Osman","year":"2021","unstructured":"Osman M, van Schalkwyk C, Naidoo P, et al. Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register. Scientific Reports. 2021;11(1):15894.","journal-title":"Scientific Reports"},{"issue":"2","key":"2175_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"2175_CR26","unstructured":"Wells G, Shea B, O'Connell D, et al. The Newcastle\u2013Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. 2000."},{"key":"2175_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"366","author":"JA Sterne","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366: l4898.","journal-title":"BMJ"},{"issue":"2","key":"2175_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/QAI.0b013e31821190a3","volume":"57","author":"CL Kvasnovsky","year":"2011","unstructured":"Kvasnovsky CL, Cegielski JP, Erasmus R, Siwisa NO, Thomas K, der Walt ML. Extensively drug-resistant TB in Eastern Cape, South Africa: high mortality in HIV-negative and HIV-positive patients. J Acquir Immune Defic Syndr. 2011;57(2):146\u201352.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"4","key":"2175_CR29","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123655","volume":"10","author":"E Pietersen","year":"2015","unstructured":"Pietersen E, Peter J, Streicher E, et al. High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis. PLoS One. 2015;10(4): e0123655.","journal-title":"PLoS One"},{"issue":"5","key":"2175_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0020077","volume":"6","author":"S Marais","year":"2011","unstructured":"Marais S, Pepper DJ, Schutz C, Wilkinson RJ, Meintjes G. Presentation and outcome of tuberculous meningitis in a high HIV prevalence setting. PLoS One. 2011;6(5): e20077.","journal-title":"PLoS One"},{"key":"2175_CR31","doi-asserted-by":"crossref","unstructured":"O\u2019Donnell MR, Padayatchi N, Kvasnovsky C, Werner L, Master I, Horsburgh CR Jr. Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection. Emerg Infect Dis. 2013;19(3):416\u201324.","DOI":"10.3201\/eid1903.120998"},{"issue":"9728","key":"2175_CR32","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(10)60492-8","volume":"375","author":"K Dheda","year":"2010","unstructured":"Dheda K, Shean K, Zumla A, et al. Early treatment outcomes and HIV status of patients with extensively drug-resistant tuberculosis in South Africa: a retrospective cohort study. Lancet. 2010;375(9728):1798\u2013807.","journal-title":"Lancet"},{"issue":"6","key":"2175_CR33","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3109\/23744235.2016.1153806","volume":"48","author":"AO Olaleye","year":"2016","unstructured":"Olaleye AO, Beke AK. Survival of smear-positive multidrug resistant tuberculosis patients in Witbank, South Africa: a retrospective cohort study. Infect Dis. 2016;48(6):422\u20137.","journal-title":"Infect Dis"},{"issue":"1","key":"2175_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/cid\/cix254","volume":"65","author":"S Janssen","year":"2017","unstructured":"Janssen S, Schutz C, Ward A, et al. Mortality in severe human immunodeficiency virus-tuberculosis associates with innate immune activation and dysfunction of monocytes. Clin Infect Dis. 2017;65(1):73\u201382.","journal-title":"Clin Infect Dis"},{"key":"2175_CR35","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1186\/s12879-015-1214-3","volume":"15","author":"T Umanah","year":"2015","unstructured":"Umanah T, Ncayiyana J, Padanilam X, Nyasulu PS. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg. South Africa BMC Infect Dis. 2015;15:478.","journal-title":"South Africa. BMC Infect Dis"},{"issue":"2","key":"2175_CR36","first-page":"405","volume":"42","author":"E Marais","year":"2014","unstructured":"Marais E, Mlambo CK, Lewis JJ, et al. Treatment outcomes of multidrug-resistant tuberculosis patients in Gauteng. South Africa Infection. 2014;42(2):405\u201313.","journal-title":"South Africa. Infection"},{"issue":"4","key":"2175_CR37","first-page":"413","volume":"14","author":"JC Brust","year":"2010","unstructured":"Brust JC, Gandhi NR, Carrara H, Osburn G, Padayatchi N. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000\u20132003. Int J Tuberc Lung Dis. 2010;14(4):413\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"5","key":"2175_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0019484","volume":"6","author":"DJ Pepper","year":"2011","unstructured":"Pepper DJ, Marais S, Wilkinson RJ, Bhaijee F, De Azevedo V, Meintjes G. Barriers to initiation of antiretrovirals during antituberculosis therapy in Africa. PLoS One. 2011;6(5): e19484.","journal-title":"PLoS One"},{"issue":"1","key":"2175_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12916-017-0822-8","volume":"15","author":"SD Lawn","year":"2017","unstructured":"Lawn SD, Kerkhoff AD, Burton R, et al. Diagnostic accuracy, incremental yield and prognostic value of Determine TB-LAM for routine diagnostic testing for tuberculosis in HIV-infected patients requiring acute hospital admission in South Africa: a prospective cohort. BMC Med. 2017;15(1):67.","journal-title":"BMC Med"},{"key":"2175_CR40","doi-asserted-by":"crossref","unstructured":"Griesel R, Stewart A, van der Plas H, Sikhondze W, Mendelson M, Maartens G. Prognostic indicators in the World Health Organization\u2019s algorithm for seriously ill HIV-infected inpatients with suspected tuberculosis. AIDS Res Ther. 2018;15(1):5.","DOI":"10.1186\/s12981-018-0192-0"},{"key":"2175_CR41","doi-asserted-by":"publisher","first-page":"3858","DOI":"10.1186\/s12879-014-0679-9","volume":"14","author":"N Field","year":"2014","unstructured":"Field N, Lim MS, Murray J, Dowdeswell RJ, Glynn JR, Sonnenberg P. Timing, rates, and causes of death in a large South African tuberculosis programme. BMC Infect Dis. 2014;14:3858.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2175_CR42","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/infdis\/jiv364","volume":"213","author":"AD Kerkhoff","year":"2016","unstructured":"Kerkhoff AD, Meintjes G, Burton R, Vogt M, Wood R, Lawn SD. Relationship between blood concentrations of hepcidin and anemia severity, mycobacterial burden, and mortality among patients with HIV-associated tuberculosis. J Infect Dis. 2016;213(1):61\u201370.","journal-title":"J Infect Dis"},{"issue":"12","key":"2175_CR43","doi-asserted-by":"publisher","first-page":"931","DOI":"10.7196\/SAMJ.5574","volume":"102","author":"MA Kendon","year":"2012","unstructured":"Kendon MA, Knight S, Ross A, Giddy J. Timing of antiretroviral therapy initiation in adults with HIV-associated tuberculosis: outcomes of therapy in an urban hospital in KwaZulu-Natal. S Afr Med J. 2012;102(12):931\u20135.","journal-title":"S Afr Med J"},{"issue":"8","key":"2175_CR44","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1093\/cid\/cix1125","volume":"66","author":"JCM Brust","year":"2018","unstructured":"Brust JCM, Shah NS, Mlisana K, et al. Improved survival and cure rates with concurrent treatment for multidrug-resistant tuberculosis-human immunodeficiency virus coinfection in South Africa. Clin Infect Dis. 2018;66(8):1246\u201353.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"2175_CR45","doi-asserted-by":"publisher","first-page":"209","DOI":"10.5588\/ijtld.11.0401","volume":"16","author":"M Loveday","year":"2012","unstructured":"Loveday M, Wallengren K, Voce A, et al. Comparing early treatment outcomes of MDR-TB in decentralised and centralised settings in KwaZulu-Natal, South Africa. Int J Tuberc Lung Dis. 2012;16(2):209\u201315.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"7","key":"2175_CR46","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1097\/INF.0b013e318253acf8","volume":"31","author":"JA Seddon","year":"2012","unstructured":"Seddon JA, Visser DH, Bartens M, et al. Impact of drug resistance on clinical outcome in children with tuberculous meningitis. Pediatr Infect Dis J. 2012;31(7):711\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"8","key":"2175_CR47","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1056\/NEJMoa0905848","volume":"362","author":"SS Abdool Karim","year":"2010","unstructured":"Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med. 2010;362(8):697\u2013706.","journal-title":"N Engl J Med"},{"issue":"2","key":"2175_CR48","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1136\/thx.2010.139048","volume":"66","author":"GJ Churchyard","year":"2010","unstructured":"Churchyard GJ, Fielding K, Roux S, et al. Twelve-monthly versus six-monthly radiological screening for active case-finding of tuberculosis: a randomised controlled trial. Thorax. 2010;66(2):134\u20139.","journal-title":"Thorax"},{"issue":"9","key":"2175_CR49","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1097\/QAD.0b013e328339e576","volume":"24","author":"M Yotebieng","year":"2010","unstructured":"Yotebieng M, Van Rie A, Moultrie H, et al. Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS. 2010;24(9):1341\u20139.","journal-title":"AIDS"},{"key":"2175_CR50","unstructured":"World Health Organization. Global Tuberculosis Programme, Global Tuberculosis Report, Data, CSV Files.2022 Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/data#csv_files [Accessed 03 Jan 2023]."},{"issue":"1","key":"2175_CR51","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1186\/s12889-019-7257-4","volume":"19","author":"KM Berry","year":"2019","unstructured":"Berry KM, Rodriguez CA, Berhanu RH, et al. Treatment outcomes among children, adolescents, and adults on treatment for tuberculosis in two metropolitan municipalities in Gauteng Province, South Africa. BMC Public Health. 2019;19(1):973.","journal-title":"BMC Public Health"},{"issue":"11","key":"2175_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0112017","volume":"9","author":"A Odone","year":"2014","unstructured":"Odone A, Amadasi S, White RG, Cohen T, Grant AD, Houben RM. The impact of antiretroviral therapy on mortality in HIV positive people during tuberculosis treatment: a systematic review and meta-analysis. PLoS One. 2014;9(11): e112017.","journal-title":"PLoS One"},{"issue":"8","key":"2175_CR53","doi-asserted-by":"publisher","first-page":"857","DOI":"10.5588\/ijtld.20.0147","volume":"24","author":"M Osman","year":"2020","unstructured":"Osman M, du Preez K, Naidoo P, et al. Key changes in the public health response to TB and HIV in South Africa. Int J Tuberc Lung Dis. 2020;24(8):857\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"10248","key":"2175_CR54","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/S0140-6736(20)31316-7","volume":"396","author":"GP Bisson","year":"2020","unstructured":"Bisson GP, Bastos M, Campbell JR, et al. Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. The Lancet. 2020;396(10248):402\u201311.","journal-title":"The Lancet"},{"issue":"10","key":"2175_CR55","doi-asserted-by":"publisher","first-page":"728","DOI":"10.7196\/SAMJ.2019.v109i10.14073","volume":"109","author":"M Loveday","year":"2019","unstructured":"Loveday M, Mzobe YN, Pillay Y, Barron P. Figures of the dead: a decade of tuberculosis mortality registrations in South Africa. S Afr Med J. 2019;109(10):728\u201332.","journal-title":"S Afr Med J"},{"issue":"7","key":"2175_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0219191","volume":"14","author":"OA Abdullahi","year":"2019","unstructured":"Abdullahi OA, Ngari MM, Sanga D, Katana G, Willetts A. Mortality during treatment for tuberculosis; a review of surveillance data in a rural county in Kenya. PLoS One. 2019;14(7): e0219191.","journal-title":"PLoS One"},{"issue":"1","key":"2175_CR57","doi-asserted-by":"publisher","first-page":"7230","DOI":"10.1038\/s41598-018-25409-5","volume":"8","author":"CPB de Almeida","year":"2018","unstructured":"de Almeida CPB, Ziegelmann PK, Couban R, Wang L, Busse JW, Silva DR. Predictors of in-hospital mortality among patients with pulmonary tuberculosis: a systematic review and meta-analysis. Sci Rep. 2018;8(1):7230.","journal-title":"Sci Rep"},{"issue":"7","key":"2175_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.5588\/ijtld.18.0433","volume":"23","author":"P Huangfu","year":"2019","unstructured":"Huangfu P, Ugarte-Gil C, Golub J, Pearson F, Critchley J. The effects of diabetes on tuberculosis treatment outcomes: an updated systematic review and meta-analysis. Int J Tuberc Lung Dis. 2019;23(7):783\u201396.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"3","key":"2175_CR59","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ijgo.2009.12.005","volume":"108","author":"J Grange","year":"2010","unstructured":"Grange J, Adhikari M, Ahmed Y, et al. Tuberculosis in association with HIV\/AIDS emerges as a major nonobstetric cause of maternal mortality in Sub-Saharan Africa. Int J Gynaecol Obstet. 2010;108(3):181\u20133.","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"2175_CR60","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0164249","volume":"11","author":"A Bekker","year":"2016","unstructured":"Bekker A, Schaaf HS, Draper HR, Kriel M, Hesseling AC. Tuberculosis disease during pregnancy and treatment outcomes in HIV-infected and uninfected women at a referral hospital in Cape Town. PLoS One. 2016;11(11): e0164249.","journal-title":"PLoS One"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02175-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13643-023-02175-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-023-02175-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T06:29:34Z","timestamp":1677133774000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-023-02175-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2175"],"URL":"https:\/\/doi.org\/10.1186\/s13643-023-02175-8","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"17 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}